
Postbiotics
Health and Industry
- 1st Edition - October 9, 2024
- Editors: Dhanasekaran Dharumadurai, Prakash M Halami
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 2 1 8 8 - 0
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 2 1 8 9 - 7
Postbiotics: Health and Industry provides a detailed overview on the fundamentals, biological and therapeutic properties, safety, and application of postbiotics in health and indus… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quotePostbiotics: Health and Industry provides a detailed overview on the fundamentals, biological and therapeutic properties, safety, and application of postbiotics in health and industry. Sections cover the fundamentals of postbiotics, which include insights on probiotic microorganisms, postbiotics, and host–microbe interaction, analysis, and characterization of postbiotics. The book goes on to delve into the different types of postbiotics and their mechanisms. Remaining sections explore various health, pharmaceutical, and industrial applications of postbiotics.
- Provides an overview on the separation, characterization, and identification of postbiotics from probiotic microbes
- Includes classes of postbiotics and their mechanisms of action
- Discusses the safety of postbiotics in humans and animals and the use of multiomics to understand the effect of postbiotics on human physiology
- Analyzes existing regulatory framework for postbiotics
- Title of Book
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- About the editors
- Foreword
- Preface
- Section 1. Fundamentals of postbiotics
- Chapter 1. Postbiotics and host–microbe interactions
- 1 Introduction
- 2 Classification of postbiotics
- 2.1 Cell-free supernatants
- 2.2 Exopolysaccharides
- 2.3 Short-chain fatty acids
- 2.4 Enzymes
- 2.5 Bacteriocins
- 3 Health benefits of postbiotics
- 4 Postbiotics mechanism of action
- 5 Postbiotics and the microbiome
- 6 The impact of postbiotics on host–microbiota interactions
- 7 Effects of postbiotics on microbial community interactions
- 8 Future perceptive and conclusion
- Chapter 2. An insight into probiotic microorganisms
- 1 Introduction
- 2 Human gut microbiota
- 3 Gut microbiota (GM) composition in diseases
- 4 The biotics family: Current knowledge in diseases
- 5 Probiotics: Protecting our health from the gut
- 6 Mechanism of action of probiotics
- 6.1 Intestinal homeostatic effects of probiotics
- 6.2 Intestinal barrier regulatory effects of probiotics
- 6.3 Immunomodulatory effects of probiotics
- 6.4 Active components and derivatives
- 7 Health effects of metabolites from probiotic bacteria
- 7.1 Short-chain fatty acids (SCFAs)
- 7.2 Plasmalogens
- 7.3 Enzymes
- 7.4 Bacteriocins
- 7.5 Exopolysaccharides (EPSs)
- 7.6 Teichoic acids
- 7.7 Vitamins
- 7.8 Biosurfactants
- 7.9 Amino acids
- 7.10 Sphingolipids
- 7.11 Extracellular polysaccharides
- 8 Evolving research from probiotics to postbiotics
- 9 Future perspectives
- 10 Conclusion
- Chapter 3. Postbiotics from Lactobacillus
- 1 Introduction
- 1.1 Significance of Lactobacillus sp. in the production of postbiotics
- 1.2 Importance of postbiotics
- 2 Postbiotics from Lactobacillus sp.
- 2.1 Overview of Lactobacillus sp.
- 2.2 Role of Lactobacillus sp. in gut health
- 2.3 Traditional application of probiotics
- 3 Lactobacillus sp. derived postbiotics
- 3.1 Production methods of postbiotics
- 3.2 Chemical analysis of postbiotics
- 4 Health benefits of postbiotics isolated from Lactobacillus sp.
- 4.1 Modulation of the immune system
- 4.2 Improvement of gut health
- 4.3 Antiinflammatory properties of postbiotics
- 4.4 Antimicrobial property of postbiotics
- 5 Application of postbiotics from Lactobacillus sp.
- 5.1 Medical application
- 5.2 Food and beverage industry
- 5.3 Milk fermentation
- 5.4 Improved shelf life
- 5.4.1 Improved shelf life of soybeans
- 5.4.2 Improved shelf life of meat
- 5.5 Cheese fermentation
- 5.6 Cosmetics and skin care products
- 5.7 Impact on animal health
- 6 Regulatory and safety considerations
- 6.1 Current regulation on postbiotics
- 6.2 Safety concern of postbiotics
- 7 Role of postbiotics in treatment of gut-related disorders
- 7.1 Role of Lactobacillus sp. in irritable bowel syndrome (IBS)
- 7.2 Role of Lactobacillus sp. in inflammatory bowel disease (IBD)
- 7.3 Role of Lactobacillus sp. in gastrointestinal infection
- 8 Clinical studies and research findings
- 8.1 Recent clinical and preclinical studies on postbiotics
- 8.2 Interaction of postbiotics and paraprobiotics with their host cell receptors
- 8.3 Recent findings and their implications
- 9 Future perspective and emerging trends
- 9.1 Current research direction
- 9.2 Detoxification
- 9.3 Regulation of the systemic metabolism
- 9.4 Immune system
- 10 Potential application and innovation
- 10.1 Immunomodulatory effects in ruminants
- 10.2 Aquaculture
- 10.3 Healthy gut microbiota in swine
- 10.4 Adding value and food safety
- 11 Challenges and limitations
- 12 Conclusions
- Chapter 4. Postbiotics from Bifidobacterium sp.
- 1 Introduction
- 2 Postbiotics
- 3 Bifidobacterium sp.
- 4 Bifidobacterium sp., as postbiotics
- 5 Preparation of Bifidobacterium sp. postbiotic
- 5.1 Cell lysis
- 6 Lyophilization
- 7 Extraction by classical solvent method
- 8 Pasteurization
- 9 Conclusion
- Chapter 5. Postbiotics from Lactococcus sp. and its biomedical applications
- 1 Introduction
- 2 Lactococcus sp. as a source of postbiotics
- 3 Biomedical applications of postbiotic components of Lactococcus sp.
- 3.1 Antibacterial activity
- 3.2 Antifungal activity
- 3.3 Antiinflammatory
- 3.4 Antiimmunomodulatory
- 3.5 Antiproliferative and antihypertensive activity
- 3.6 Secondary metabolite compound
- 4 Conclusion
- Chapter 6. Investigation of postbiotic from Saccharomyces sp. and its biotherapeutic applications
- 1 Introduction
- 2 Saccharomyces spp. as a source of postbiotics
- 3 Biotherapeutic efficacy of postbiotic components of Saccharomyces spp.
- 3.1 Antimicrobial activity
- 3.2 Anticancer activity
- 3.3 Antioxidant activity
- 3.4 Antidiabetic activity
- 4 Conclusion
- Chapter 7. Oral microbiome and human health
- 1 Development of the oral microbiome
- 2 The human microbiome project
- 3 Functions of the oral microbiome
- 4 Oral bacterial microbiome
- 5 Oral microbiome and diseases
- 5.1 Periodontitis
- 5.2 Dental caries
- 5.3 Halitosis
- 6 Oral bacteria and systemic diseases
- 6.1 Tumor
- 6.2 Diabetes mellitus
- 6.3 Cardiovascular Diseases
- 6.4 Respiratory diseases
- 6.5 Bacteremia
- 6.6 Alzheimer’s
- 6.7 Preterm Birth
- 7 Oral fungal, viral, protozoan, and archaeal microbiome
- 7.1 Fungal microbiome
- 7.2 Viral microbiome
- 7.3 Protozoan microbiome
- 7.4 Archaeal microbiome
- 8 Conclusion
- Chapter 8. Separation, characterization and identification of postbiotics from probiotic microbes
- 1 Introduction
- 2 Postbiotics and well known probiotics
- 3 Production and separation of postbiotics from probiotic bacteria
- 4 Characterization of postbiotics
- 4.1 Gas chromatography
- 4.2 Liquid chromatography
- 4.3 Fourier-infrared transform spectroscopy
- 4.4 NMR spectroscopy
- 4.5 Spectrophotometric analysis
- 4.6 Other techniques
- 5 Health benefits of postbiotics obtained from probiotic organisms
- 6 Conclusion
- Chapter 9. Genomic characterization of postbiotics
- 1 Discovery of probiotics
- 2 Definition of pro-, pre-, syn-, and postbiotics
- 3 Applications of probiotics
- 3.1 Probiotics on human health
- 3.2 Probiotics on poultry and animal health
- 4 Critical issues of probiotics
- 5 Postbiotics
- 6 Applications of postbiotics
- 7 Genomic characterization of postbiotics
- 7.1 Genomic characterization of lactic acid bacteria (LAB)
- 7.1.1 Bacillus velezensis
- 7.2 Genomic characterization of Corynebacterium amycolatum
- 7.2.1 Stress response genes
- 7.2.2 Genes responsible for secondary metabolite biosynthesis
- 7.2.3 H2O2-related genes
- 7.2.4 Nutrient production
- 7.3 Genomic characterization of Bifidobacterium longum
- 7.3.1 pH and bile salt tolerance
- 7.3.2 Bacterial adhesion
- 8 Conclusion
- Chapter 10. Unlocking health potential of postbiotics: Exploring there potential and overcoming challenges
- 1 Introduction
- 2 Importance of postbiotic
- 3 Classification of postbiotics
- 3.1 Short-chain fatty acids
- 3.2 Exopolysaccharides
- 3.3 Enzymes
- 3.4 Cell wall fragments
- 3.5 Cell-free supernatants
- 3.6 Bacterial lysates
- 3.7 Other metabolites
- 4 Methods for obtaining and identifying postbiotics
- 5 Bioactivity and consequences of postbiotics
- 5.1 A possible mechanism for postbiotic activity
- 6 Postbiotic applications in food production and healthcare
- 6.1 Postbiotics potential role in food industry
- 6.2 The potential role of postbiotics in the pharmaceutical or health industry
- 7 Future impact of postbiotics on probiotic vision for future research
- 8 Challenges and safety regulations of postbiotics
- 9 Limitations of postbiotics
- 10 Conclusion
- Section 2. Postbiotics types and mechanisms
- Chapter 11. Exopolysaccharides: Exploring their role as postbiotics
- 1 Introduction
- 1.1 Exopolysaccharide as postbiotics
- 1.2 Health-promoting benefits of postbiotics produced by lactic acid bacteria: Exopolysaccharide
- 1.3 Health-promoting benefits of postbiotics produced by yeast: Exopolysaccharide
- 2 Structure and classification of EPS—Physical properties of EPS
- 2.1 Exopolysaccharides (EPS): Structure, classification, and physical properties
- 2.1.1 Biosynthetic pathway of EPS
- 3 Functional and health-based importance of EPS
- 3.1 Immunomodulatory activities
- 3.2 Antiinflammatory effects
- 3.3 Antitumor and antimutagenicity
- 3.3.1 Antitumor activity
- 3.3.2 Antimutagenicity
- 4 Modulation of gene expression
- 4.1 Antioxidant activity
- 4.2 Antibacterial and antiviral activity
- 4.3 Antiviral activity
- 4.4 Cholesterol lowering and antidiabetic properties
- 4.5 Antidiabetic properties
- 4.6 Gastroprotective activity
- 4.7 Antibiofilm activity
- 5 Conclusion
- Chapter 12. Short-chain fatty acids as postbiotics
- 1 Introduction
- 2 Microbiome and human health
- 3 Production of SCFA in vivo
- 4 SCFA-producing microbes in the gut
- 5 Metabolism and signal pathways of SCFA
- 6 Biological functions of SCFA
- 6.1 SCFA and colonic epithelium integrity
- 6.2 SCFA and metabolic effects
- 6.3 SCFA and antitumor activity
- 6.4 SCFA and immunity
- 6.5 SCFA and gut–brain communication
- 7 Applications of SCFA as postbiotic
- 7.1 Delivery strategies of SCFA
- 7.2 Diet regulation
- 7.3 “Postbiotic” delivery
- 8 Conclusions and future perspectives
- Chapter 13. Enzymes and vitamins from probiont as postbiotics: A review
- 1 Introduction
- 2 Classification of postbiotics
- 2.1 Short-chain fatty acids (SCFAs)
- 2.2 Peptides and proteins
- 2.3 Exopolysaccharides (EPS)
- 2.4 Bacteriocins
- 2.5 Nucleotides
- 2.6 Other postbiotic compounds
- 2.7 Enzymes from postbiotics
- 3 Vitamins used in postbiotics
- 4 Industrial importance of postbiotics
- 4.1 Importance of postbiotics in food and beverages industries
- 4.2 Importance of postbiotics in pharmaceuticals industries
- 4.3 Importance of cosmetics and skin care industries
- 4.4 Importance of postbiotics in animal feed and agriculture industries
- 5 Uses of postbiotics
- 5.1 Modulates immune system
- 5.2 Antitumor effects
- 5.3 Prevention of infection
- 5.4 Used in arthrosclerosis
- 5.5 Use in allergic diseases
- 5.6 Industrial production of vitamins and enzymes
- 5.7 Example:Vitamin B1
- 5.8 Example 2: Vitamin B12
- 5.9 Example 3: Vitamin C
- 5.10 Example 4: Vitamin A
- 6 Application of postbiotics
- 6.1 Medical application of postbiotics
- 6.2 Agricultural applications of postbiotics
- 6.3 Other application of postbiotics
- 7 Conclusion
- Chapter 14. Bacteriocins or microbial peptides produced by probiotics
- 1 Introduction
- 2 Classification of bacteriocins and microbial peptides
- 3 Overview of the definitions of terms, connected with bacteriocins, bioactive peptides, and probiotics
- 4 Methodology of research
- 5 Bacteriocins or bioactive peptides produced by probiotics and other beneficial microbes
- 5.1 Bacteriocins or bioactive peptides produced by lactobacilli strains
- 5.2 Bacteriocins or bioactive peptides produced by bifidobacteria strains
- 5.3 Bacteriocins or bioactive peptides produced by bacteria other than lactobacilli and bifidobacteria strains
- 6 Characteristics of identified studies on bacteriocins or bioactive peptides
- 7 Conclusions
- Chapter 15. Mechanisms of postbiotics
- 1 Introduction
- 2 Modulation of the gut microbiota
- 3 Antimicrobial activity
- 4 Intestinal adaptations
- 5 Immunomodulation
- 5.1 Inactive microorganisms and cell fragments
- 5.2 Peptidoglycan
- 5.3 Lipoteichoic acids
- 5.4 Exopolysaccharide
- 5.5 Short-chain fatty acids
- 5.6 Bacteriocins
- 6 Metabolic adaptations
- 7 Conclusion and perspectives
- Chapter 16. Commercially available human and animal postbiotics
- 1 Introduction
- 2 Classification of postbiotics
- 2.1 Short-chain fatty acids
- 2.2 Exopolysaccharides
- 2.3 Enzymes
- 2.4 Cell wall fragments
- 2.5 Cell-free supernatants
- 2.6 Bacterial lysates
- 2.7 Other metabolites
- 3 Commercially available human and animal postbiotics
- 3.1 HT-BPL1
- 3.2 Del-Immune V
- 3.3 CytoFlora
- 3.4 Hylak forte
- 3.5 Epicor
- 3.6 LAC-shield
- 3.7 Pylopass
- 3.8 HK L-137
- 3.9 Totipro
- 3.10 Lactobacillus fermentate
- 3.11 LivaltaTMCell HY40
- 3.12 NutriTek
- 3.13 SafMannan
- 4 Addressing the knowledge gap in postbiotic advancements
- 4.1 A lack of standardization and regulatory oversight
- 4.2 Scarcity of technical expertise in postbiotic manufacturing
- 4.3 Inadequate clinical studies
- 4.4 Limited data on adverse effects of postbiotics consumption
- 5 Emerging trends in the postbiotics utilization
- 5.1 Postbiotics in the therapeutic field
- 5.2 Postbiotics as performance enhancers
- 5.3 Postbiotics as dietary supplements for infants
- 5.4 Precision postbiotics
- 5.5 Nanotechnology for targeted postbiotics delivery
- 6 Conclusions
- Chapter 17. Postbiotic effects on drug metabolism and therapeutic outcomes
- 1 Introduction
- 2 Existing classes of postbiotic drugs
- 2.1 Cell free supernatants
- 2.2 Exopolysaccharides (EPSs)
- 2.3 Enzymes
- 2.4 Cell wall fragments
- 2.5 Bacterial lysates
- 3 Postbiotic action mechanism
- 3.1 Immunostimulating effects
- 3.2 Prevention of infection
- 3.3 Anticancer effects
- 3.4 Antiatherogenic effects
- 3.5 Rapid wound healing
- 4 Therapeutic outcomes
- 4.1 Manufacturing technology
- 4.2 Usage safety
- 4.3 Functional food products
- 4.4 Utilization in allergic diseases
- 5 Future clinical applications
- 6 Conclusion
- Chapter 18. Modulation of human gut dysbiosis by postbiotics
- 1 Introduction
- 2 Causes that trigger gut dysbiosis
- 3 Gut dysbiosis in clinical disorders
- 4 Convection therapeutic treatments for gut dysbiosis and their disadvantages
- 5 Next-generation therapeutics—postbiotic therapy
- 6 Postbiotics efficacy mechanisms in stabilizing gut microbiota
- 6.1 Protective modulation against gut pathogens
- 6.2 Enhancing the intestinal wall barrier
- 6.3 Immunomodulatory activity
- 7 Commercially available postbiotics in gut dysbiosis treatment
- 8 Future prospects of postbiotics in gut dysbiosis treatment
- Chapter 19. Meta-analysis of postbiotics on evaluating health benefits and mechanisms
- 1 Introduction
- 2 Gut biota and its metabolome
- 3 Conception of postbiotics and mechanism of action of microbial-derived biotics (meta/pharma/postbiotics)
- 4 Analysis of the microbiome and probiotics by bioinformatics and metabolomics
- 5 Potential effects of postbiotics on intestinal epithelial barrier integrity
- 6 Beneficial effects of the essential biotics on gut biota
- 6.1 Bacteriocins
- 6.2 Exopolysaccharides (EPS)
- 6.3 γ-aminobutyric acid (GABA)
- 6.4 Short-chain fatty acids (SCFAs) and polyunsaturated fatty acids (PUFAs)
- 6.5 Structural compounds and dead cells
- 7 Precision and prospective role of postbiotics in mental health
- 7.1 Postbiotic and depression
- 7.2 Postbiotic and anxiety
- 7.3 Postbiotic and cognitive function
- 7.4 Postbiotic and other CNS states
- 8 Prospective role of postbiotics in innate and adaptive immunity
- 9 Conclusion and future perspectives
- Section 3. Applications of postbiotics in health and pharmaceutical industry
- Chapter 20. Postbiotics: A health promoters in human
- 1 Introduction
- 2 Sources and types of postbiotics
- 3 Diverse origins of postbiotics
- 4 Prominent types of postbiotics
- 4.1 Short-chain fatty acids
- 4.2 Exopolysaccharides
- 4.3 Lipopolysaccharides (LPS)
- 4.4 Enzymes and cellular components
- 4.5 Others
- 5 Mechanism and biological activities of postbiotics
- 6 Health benefits of postbiotics
- 6.1 Improved gut health
- 6.2 Enhancement of immune system function
- 6.3 Antiinflammatory and antioxidant properties
- 6.4 Metabolic effects and disease prevention
- 7 Applications of postbiotics
- 8 Conclusions
- Chapter 21. Integrative multiomics: Understanding postbiotics and their role in human physiology
- 1 Introduction
- 2 Probiotics, their action modality
- 3 Conceptualization of postbiotics
- 4 Application of multiomics in the metamorphosis of commensal microbiota into target-based probiotics
- 5 Postbiotic components: Production and characterization
- 6 Postbiotics function health benefits
- 7 What factors govern the efficacy of probiotics and postbiotics in given circumstances?
- 7.1 What criteria should be met for the formation of probiotics and postbiotics intended for human use?
- 7.2 Why do certain probiotics and postbiotic perform inadequately in preclinical and clinical trials?
- 7.3 Why should host-adapted strains be favored for probiotic and postbiotic formulations?
- 7.4 Humane use of strategically formulated probiotics and postbiotics
- 8 Perspectives for nonclinical application
- 8.1 Biopreservation
- 8.2 Functional food preparation
- 8.3 Food packaging
- 8.4 Cosmetic applications
- 9 Future prospects
- 10 Conclusion
- Chapter 22. Antimicrobial effects of postbiotics
- 1 Introduction
- 1.1 What are antibiotics and antimicrobials?
- 1.2 Why do we need alternatives?
- 1.3 What are postbiotics?
- 2 Mode of action of postbiotics
- 2.1 Action by lactic acid bacteria
- 2.1.1 Lactobacillus johnsonii and Lactobacillus acidophilus
- 2.1.2 Lactobacillus plantarum
- 2.1.3 Lactobacillus rhamnosus
- 2.1.4 Lactobacillus acidophilus LB on ETEC
- 2.1.5 Lactobacillus acidophilus LB on Salmonella spp.
- 2.1.6 Lactobacillus paracasei and Lactobacillus rhamnosus on E. coli
- 2.1.7 L. casei, L. sporogenes, S. faecalis, C. butyricum, B. mesentericus on Cronobacter sakazakii
- 2.1.8 Lactobacillus gasseri
- 2.2 Action of Bifidobacterium bifidum
- 2.3 Action of Enterococcus faecium
- 3 Discussion
- Chapter 23. Prevention of microbial infections by postbiotic
- 1 Introduction
- 2 Therapeutic effects of postbiotics in preventing microbial infections
- 2.1 Postbiotic mode of action (A general background)
- 2.2 Clinical evidence based on postbiotics mode of action
- 3 An overview of postbiotic production to prevent microbial infections
- 4 Conclusion
- Chapter 24. Prevention of food allergies using postbiotics
- 1 Introduction
- 2 Role of gut microbiome in food allergy
- 3 Role of postbiotics on host-microbiome interaction
- 4 Immunomodulatory effects of postbiotics
- 5 Mechanism of action of postbiotics
- 6 Role of postbiotics in food
- 7 Mechanism of postbiotics in food allergy
- 8 Future perspectives of postbiotics
- 9 Conclusion
- Chapter 25. Anticancer and antioxidant activity of postbiotics
- 1 Introduction
- 2 The concept of postbiotics
- 3 Anticancer activity of postbiotics
- 4 Antioxidant activity of postbiotics
- 5 Antioxidant mechanism of postbiotics
- 5.1 Superoxide dismutase
- 5.2 Glutathione peroxidases
- 5.3 Catalase
- 6 Conclusions and prospects
- Chapter 26. Antioxidant activity of postbiotics
- 1 Introduction
- 2 Antioxidant properties of postbiotics
- 2.1 Detailed exploration of the antioxidant activity exhibited by postbiotics
- 2.2 Chemical composition of postbiotics contributing to their antioxidant capacity
- 2.3 Mechanisms of action involved in the antioxidant effects of postbiotics
- 3 Role of postbiotics in health promotion
- 3.1 Impact of postbiotics on oxidative stress and its relevance to human health
- 3.2 Exploration of postbiotics as natural alternatives to synthetic antioxidants in health promotion
- 4 Applications of postbiotics in the pharmaceutical industry
- 4.1 Use of postbiotics as natural antioxidants in pharmaceutical formulations
- 4.2 Advantages of postbiotics over synthetic antioxidants
- 4.3 Potential therapeutic applications of postbiotics
- 4.4 Research advancements and clinical trials involving postbiotics in the pharmaceutical sector
- 5 Gut microbiota modulation by postbiotics
- 5.1 Influence of postbiotics on the gut microbiota composition and diversity
- 5.2 Role of a balanced gut microbiota in maintaining redox homeostasis and reducing oxidative stress
- 6 Applications of postbiotics in the food industry
- 6.1 Functional food production
- 6.2 Shelf life extension and food preservation
- 6.3 Food packaging
- 6.4 Safety issues of postbiotics
- 7 Challenges of using postbiotics as antioxidant compounds
- 8 Potential areas for further research and future perspectives
- Chapter 27. Antiinflammatory effects of postbiotics
- 1 Introduction
- 2 Antiinflammatory activity of postbiotics
- 2.1 Cell-free supernatants
- 2.2 Short-chain fatty acids
- 2.3 Exopolysaccharides
- 2.4 Lipoteichoic acid
- 2.5 Metabolites
- 2.6 Cell wall components
- 2.7 Heat-killed cells
- 2.8 Proteins
- 3 Are postbiotics a holistic alternative to conventional antiinflammatory therapies?
- 4 Conclusion and future implications
- Chapter 28. Antiatherosclerotic effects of postbiotics
- 1 Cardiovascular disease
- 2 Atherosclerosis—A chronic inflammatory disease
- 3 Immunology behind atherosclerosis
- 4 Treatment options for atherosclerosis
- 5 Antiatherosclerosis
- 6 Antiatherosclerotic effects of natural products
- 7 All about biotics
- 7.1 Probiotics
- 7.2 Prebiotics
- 7.3 Symbiotics
- 7.4 Postbiotics
- 8 Lactobacilli
- 9 Postbiotic metabolites produced by intestinal gut-microbiota which help in prevention of atherosclerosis
- 9.1 Heart disease: A role for metabolites released by the gut microbiota
- 9.2 Exopolysaccharides: A postbiotic metabolite
- 9.3 Short-chain fatty acids (SCFAs): A postbiotic metabolite
- 10 Conclusion
- Section 4. Applications of postbiotics in nonhuman host
- Chapter 29. Postbiotic metabolites in livestock feeding
- 1 Introduction
- 2 Production and classification of postbiotic components
- 2.1 Exopolysaccharides
- 2.2 SCFAs (short-chain fatty acids)
- 2.3 Cell wall components
- 2.4 Antimicrobial peptides
- 2.5 Vitamins
- 3 Beneficial effects of postbiotics on livestock gut health
- 4 Postbiotics feed supplement for pigs
- 5 Postbiotics feed supplement for chicks
- 6 Postbiotics feed supplement for goat and cow
- 7 Conclusion
- Chapter 30. Postbiotics metabolites in aquaculture
- 1 Introduction
- 2 Health-promoting effects of postbiotics effects in the host species (nonhuman)
- 2.1 Postbiotic effects of Bacillus velezensis FS26 in giant freshwater prawn against Aeromonas and Vibrio spp.
- 2.2 Postbiotic effects of Bacillus velezensis GY65 in mandarin fish (Siniperca chuatsi) against Aeromonas hydrophila GYK1
- 2.3 Postbiotic effects of Bacillus subtilis in bullfrog against Mycoplasma
- 2.4 Postbiotics effects of Bacillus subtilis in rainbow trout and Nile tilapia against Yersinia ruckeri and Aeromonas salmonicida subsp. salmonicida
- 2.5 Postbiotic effects of Spirochetes and Bacteroidetes in rainbow trout against Lactococcus garvieae infection
- 2.6 Postbiotic effects in shrimp species against shrimp vibriosis and other infections
- 3 Applications of postbiotics in aquaculture
- 4 Conclusion
- Chapter 31. Growth and immunomodulatory postbiotic effects in fish
- 1 Introduction
- 1.1 Postbiotic components: Production and characterization
- 1.2 Possible signaling mechanisms
- 1.3 Microbial strains as a postbiotic source
- 1.4 Methodologies to identify and obtain postbiotics
- 1.4.1 Postbiotics and immune system
- 1.4.2 Inactivated and dead probiotics (nonviable probiotics)
- 1.5 Cell-free suspensions
- 1.5.1 Exopolysaccharides and extracellular vesicle
- 1.5.2 Bacterial lysates
- 1.5.3 Vitamins
- 1.5.4 Biosurfactants
- 1.5.5 Short-chain fatty acids
- 1.5.6 Bacteriocins
- 1.6 Toll-like receptor (TLR)
- 1.7 Nucleotide-binding and oligomerization receptor (NLR)
- Chapter 32. Growth and immunomodulatory postbiotic effects in shrimp
- 1 Introduction
- 1.1 Background of shrimp aquaculture and its challenges
- 1.2 The emergence of probiotics and prebiotics in shrimp farming
- 2 Postbiotics: Definition and sources
- 2.1 Definition and classification of postbiotics
- 2.2 Sources of postbiotics in shrimp farming
- 3 Growth-promoting postbiotic effects in shrimp
- 4 Immunomodulatory postbiotic effects
- 4.1 Immune system of shrimps
- 4.2 Disease resistance in shrimp
- 4.3 Evaluation of immunological parameters
- 4.3.1 Hemocyte count
- 4.3.2 Phagocytic activity assay
- 4.3.3 Total plasma protein
- 4.3.4 Preparation of hemocyte lysate supernatant (HLS)
- 4.3.5 Bacterial clearance efficiency
- 5 Formulation and delivery of postbiotics in shrimp
- 5.1 Encapsulation techniques for postbiotic stability
- 5.2 Dosing of postbiotics in shrimp aquaculture
- 6 Assessing the safety of postbiotics in shrimp farming
- 7 Conclusion
- Chapter 33. Immunomodulatory and growth-enhancing postbiotic effects in poultry
- 1 Introduction
- 2 Types of postbiotic products: nonviable probiotics
- 3 Exopolysaccharide
- 4 Teichoic acid
- 5 Probiotic bacterial vesicles
- 6 Fermented products
- 7 Surface-layer proteins
- 8 Short-chain fatty acids
- 9 Probiotic enzymes
- 10 Probiotic metabolites
- 11 Yeast extract: A key component in postbiotics
- 12 Bacterial lysate: Implications for the gut–lung axis
- 13 Mechanism of action: postbiotics
- 14 Lactobacillus-derived supernatants: A trove of postbiotics
- 15 Postbiotics and the poultry gut microbiome
- 16 Growth enhancement in poultry through postbiotics
- 17 Immunomodulatory effects of postbiotics on poultry
- 18 Conclusion
- Chapter 34. Growth and immunomodulatory postbiotic effects in mice
- 1 Introduction
- 2 Gut microbiota
- 3 Postbiotics
- 3.1 Probiotic bacteria-producing postbiotics
- 3.2 Classification of postbiotics
- 4 Postbiotics and immune system
- 4.1 Postbiotics and immune system modulation (Yeşilyurt et al., 2021)
- 5 The impact of postbiotics on host–microbiota interactions
- 6 Safety of postbiotics
- 7 Immunomodulatory effects on gut
- 8 Gamma-aminobutyric acid (GABA)
- 8.1 Screening for GABA production
- 8.2 High-performance thin-layer chromatography
- 8.3 Effects of GABA on immune cells
- 9 Animals
- 9.1 Lymph node cells isolation
- 9.2 Lactate dehydrogenase assay
- 9.3 MTT assay on lymph node cells
- 9.4 Quantification of cytokines
- 9.5 Mice hemagglutination test
- 9.6 Cell cytotoxicity and proliferation
- 10 Immunomodulatory
- 10.1 Neurotransmitter-mediated immunomodulation
- 10.1.1 Glutamate
- 10.1.2 Humoral antibody (HA) response
- 10.1.3 Macrophage phagocytic index in mice
- 10.1.4 Delayed-type hypersensitivity
- 10.1.5 Serum hemolysin level
- 10.1.6 Immune organ index
- 10.1.7 Monitoring blood glucose level
- 10.1.8 Oral glucose tolerance test
- 11 Development of GABA-enriched fermented juices
- 12 Growth
- 13 Function
- 14 Conclusion
- Section 5. Applications of postbiotics in food industry
- Chapter 35. Biopreservation of dairy products using postbiotics
- 1 Introduction
- 2 Overview of postbiotics
- 3 Role of postbiotics in biopreservation and mechanism of action
- 4 Organic acids and bacteriocins
- 5 Enzymes
- 6 Applications of postbiotics in dairy products
- 7 Dairy products preservation and safety
- 8 Cheese production and ripening with postbiotics
- 9 Yogurt and fermented milk products preservation
- 10 Butter and other dairy product applications
- 11 Benefits and challenges of postbiotic biopreservation
- 12 Future perspectives
- 13 Conclusion
- Chapter 36. Biopreservation of fruits and vegetables using postbiotics
- 1 Introduction
- 1.1 Classification of postbiotics
- 1.2 Advantages of postbiotics
- 2 Exopolysaccharides
- 3 Antimicrobial peptides (AMPs)
- 4 Organic acid
- 4.1 Applications in the preservation of fruits and vegetables
- 4.2 Application of citric acid in the food industry
- 5 Short-chain fatty acids (SCFAs)
- 6 Vitamins
- 6.1 Applications of vitamins in food
- 7 Phenolic derivatives
- 7.1 Applications of phenolic derivatives in fruits and vegetables
- 8 Cell wall fragments
- 8.1 Applications in the food industry
- 9 Conclusion
- Chapter 37. Bacteriocin-based approach for food preservation
- 1 Introduction
- 2 Bacteriocin: Nature and characteristics
- 3 Classification of bacteriocins
- 4 Criteria of bacteriocin to be a food preservative
- 5 Application method of bacteriocin as a food preservative
- 6 Mode of action of bacteriocin
- 7 Bacteriocin in food preservation
- 8 Nisin
- 9 Pediocin
- 10 Enterocins
- 11 Applications of bacteriocin to food
- 12 Conclusion
- Chapter 38. Postbiotics food packing using bacteriocin
- 1 Introduction
- 2 Bacteriocin
- 2.1 Classification of bacteriocins
- 2.2 Nisin
- 2.2.1 Physiological properties of nisin
- 2.2.2 Applications of nisin in food products
- 2.3 Pediocin
- 2.3.1 Physiological properties of pediocin
- 3 Discussion and conclusion
- Chapter 39. Antibiofilm activity of postbiotics
- 1 Introduction
- 2 Materials
- 2.1 Preparation of primary inoculum for the desired probiotic strain for the extraction of postbiotics
- 2.2 Culturing and preparation of cell-free supernatant for the extraction of postbiotics
- 2.3 Extraction of postbiotics from cell-free supernatant of microbial culture
- 2.4 Determination of minimum inhibitory concentration (MIC) of extracted postbiotics
- 2.5 Determination of biofilm inhibitory concentration (BIC) and percentage of biofilm inhibition for the extracted postbiotics
- 2.6 Evaluation of metabolic viability of biofilm cells upon treatment with postbiotics by Alamar blue assay
- 2.7 Evaluation of metabolic viability of biofilm cells upon treatment with postbiotics by XTT assay
- 2.8 Quantification of EPS in biofilms treated with postbiotics
- 2.9 Determining the efficacy of postbiotics in eradication of mature or preformed biofilms
- 2.10 Evaluation of biofilm inhibition by microscopy
- 2.10.1 Observation of biofilm inhibitory potential of postbiotics using confocal laser scanning microscopy
- 2.10.2 Observation of biofilm inhibitory potential of postbiotics using scanning electron microscopy
- 3 Methods
- 3.1 Preparation of primary inoculum for the desired probiotic strain for the extraction of postbiotics (Azami et al., 2022)
- 3.2 Culturing and preparation of cell-free supernatant for the extraction of postbiotics (Azami et al., 2022; Rossoni et al., 2020)
- 3.3 Extraction of postbiotics from cell-free supernatant of microbial culture (Azami et al., 2022; Rossoni et al., 2020)
- 3.4 Determination of minimum inhibitory concentration (MIC) of extracted postbiotics (Azami et al., 2022)
- 3.5 Determination of biofilm inhibitory concentration (BIC) and percentage of biofilm inhibition for the extracted postbiotics (Gowrishankar et al., 2012)
- 3.6 Evaluation of metabolic viability of biofilm cells upon treatment with postbiotics by Alamar blue assay (Squarzanti et al., 2022)
- 3.7 Evaluation of metabolic viability of biofilm cells upon treatment with postbiotics by XTT assay (Azami et al., 2022)
- 3.8 Quantification of EPS in biofilm treated with postbiotics (Gowrishankar et al., 2012)
- 3.9 Determining the efficacy of postbiotics in eradication of mature or preformed biofilms (Ishikawa et al., 2021)
- 3.10 Evaluation of biofilm inhibition by microscopy
- 3.10.1 Observation of biofilm inhibitory potential of postbiotics using light microscope (Zhao et al., 2023)
- 3.10.2 Observation of biofilm inhibitory potential of postbiotics using scanning electron microscopy (Zhao et al., 2023)
- Chapter 40. Biodegradation of mycotoxins using postbiotics
- 1 Introduction to postbiotics in the food industry
- 1.1 Definition and characteristics of postbiotics
- 1.2 Importance and potential applications in the food industry
- 2 Overview of mycotoxins in food
- 2.1 Definition and sources of mycotoxins
- 2.2 Regulatory guidelines for mycotoxin limits in food
- 3 Postbiotics and mycotoxin biodegradation
- 3.1 Role of postbiotics in mycotoxin degradation
- 3.2 Mechanisms of mycotoxin biodegradation by postbiotics
- 3.3 Factors influencing the efficiency of mycotoxin biodegradation
- 4 Postbiotic strains for mycotoxin biodegradation
- 4.1 Selection and isolation of postbiotic strains with mycotoxin degradation potential
- 4.2 Characterization and identification of effective postbiotic strains
- 4.3 Safety assessment of postbiotic strains for food applications
- 5 Biodegradation of specific mycotoxins by postbiotics
- 5.1 Aflatoxins: Degradation mechanisms and postbiotic strains involved
- 5.2 Ochratoxin A: Biodegradation pathways and postbiotic strains
- 6 Applications of postbiotic-based mycotoxin detoxification
- 6.1 Mechanisms of postbiotic-based mycotoxin detoxification
- 6.2 Postharvest treatment of mycotoxin-contaminated crops
- 6.3 Detoxification of mycotoxins during food processing
- 6.4 Use of postbiotics as a preventive measure for mycotoxin contamination
- 7 Safety and regulatory aspects
- 7.1 Safety evaluation of postbiotic-treated food products
- 7.2 Challenges and future perspectives in postbiotic application for mycotoxin control
- Chapter 41. Preservation of postbiotics
- 1 Introduction
- 2 Biopreservation
- 3 Biopreservation of vegetables and bread
- 4 Biopreservation of dairy products
- 5 Functional food preparation
- 6 Food packaging
- 7 Removal of biofilms
- Chapter 42. Postbiotics-promising role as energetic biomolecules, safety regulations, and nutritional aspects
- 1 Introduction to postbiotics
- 1.1 Food to postbiotics: The journey of microbial metabolites
- 1.1.1 Microbiota's role in food transformation
- 1.2 Definition and characteristics of postbiotics
- 1.2.1 Clarifying the terminology
- 1.2.2 Distinguishing postbiotics from probiotics and prebiotics
- 1.2.3 The distinct identity of postbiotics
- 1.3 Importance of postbiotics in gut health and beyond
- 1.3.1 Linking gut microbiota and overall health
- 1.4 Expanding the reach of postbiotics: Skin, immune system, and more
- 2 Postbiotics as energetic biomolecules
- 2.1 Short-chain fatty acids (SCFAs) as key energetic components
- 2.1.1 Composition and origins
- 2.1.2 Energy yield and metabolism
- 2.1.3 Butyrate's dual role
- 2.1.4 Metabolic signaling
- 2.1.5 Nutrient utilization and beyond
- 2.2 Amino acids and peptides as energy sources
- 2.2.1 Microbial conversion of protein-derived metabolites
- 2.2.2 Utilization in energy metabolism
- 2.2.3 Other metabolites with energetic potential
- 2.3 Role of postbiotics in cellular energy metabolism
- 2.3.1 Mitochondria and cellular energy metabolism
- 2.3.2 Impact on cellular ATP production
- 2.3.3 Interactions with energy-regulating pathways
- 3 Safety regulations and oversight
- 3.1 Current regulatory framework for postbiotic products
- 3.1.1 FDA (food and drug administration) guidelines
- 3.1.2 EFSA (European Food Safety Authority) regulations
- 3.1.3 DST guidelines for probiotics
- 3.2 Assessment of safety and potential risks
- 3.2.1 Toxicological studies and safety evaluations
- 3.2.2 Allergenicity and adverse reactions
- 3.2.3 Microbial contamination and quality control
- 4 Postbiotics as nutrient sources
- 4.1 Bioavailability of postbiotic compounds
- 4.2 Impact on essential nutrient absorption
- 4.3 Health benefits of incorporating postbiotics into the diet
- 4.3.1 Gut health improvement and microbiota modulation
- 4.3.2 Immune system enhancement
- 4.3.3 Potential for metabolic health and weight management
- 5 Applications and future perspectives
- 5.1 Industrial applications of postbiotics
- 5.1.1 Postbiotics in food and beverage industries
- 5.1.2 Pharmaceutical and nutraceutical applications
- 5.1.3 Cosmetics and personal care products
- 5.2 Exploring future research avenues
- 5.2.1 Novel postbiotic sources and production techniques
- 5.2.2 Postbiotics and personalized nutrition
- 5.2.3 Clinical trials and therapeutic potential
- 6 Conclusion
- Index
- No. of pages: 786
- Language: English
- Edition: 1
- Published: October 9, 2024
- Imprint: Academic Press
- Paperback ISBN: 9780443221880
- eBook ISBN: 9780443221897
DD
Dhanasekaran Dharumadurai
Dr. Dharumadurai Dhanasekaran is a Professor in the Department of Microbiology, Principal Investigator in National Repository for Microalgae and Cyanobacteria—Freshwater (NRMC-F) at Bharathidasan University in Tiruchirappalli, India. His research experience is in the fields of actinobacteriology and mycology. His current research focuses on probiotic microorganisms and postbiotics and microbiome profiling in plant and animal system. He has been awarded an UGC-Raman Post-Doctoral Fellowship and has worked in the Department of Molecular, Cellular, and Biomedical Sciences at the University of New Hampshire in Durham, USA. He studied the genome properties of probiotic bacteria by whole genome, metagenome sequencing, and formulated probiotic feed supplements for dairy cow. He edited 17 books with international publishers and served as a reviewer, guest editor, and on the editorial boards of national and international journals.
PH